ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,731.10
      0.22%
      US Tech 100
      19,435.60
      0.59%
      Dow Jones
      42,151.43
      0.06%
      Brent Oil
      74.405
      0.91%
      Bitcoin
      63,326.81
      0.00%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Geron Corp (GERN) Quote

      Geron Corp

      Geron Corp (GERN)

      NASDAQ
      4.465
      0.185
      ( 4.32% )
      Updated: 12:39:31
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      4.465
      Bid
      4.46
      Ask
      4.47
      Volume
      3,889,766
      4.30 Day's Range 4.50
      1.64 52 Week Range 5.34
      Market Cap
      2.691B
      Previous Close
      4.28
      Open
      4.31
      Last Trade
      100
      @
      4.465
      Last Trade Time
      12:39:31
      Financial Volume
      $ 17,203,303
      VWAP
      4.4227
      Average Volume (3m)
      9,152,898
      Shares Outstanding
      602,795,563
      Dividend Yield
      -
      PE Ratio
      -14.60
      Earnings Per Share (EPS)
      -0.31
      Revenue
      237k
      Net Profit
      -184.13M

      About Geron Corp

      Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a ... Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.geron.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Geron Corp is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GERN. The last closing price for Geron was $4.28. Over the last year, Geron shares have traded in a share price range of $ 1.64 to $ 5.34.

      Geron currently has 602,795,563 shares outstanding. The market capitalization of Geron is $2.58 billion. Geron has a price to earnings ratio (PE ratio) of -14.60.

      Ask ADVFN Intelligence (AI)

      GERN Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      4 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      4 hours ago

      Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 500,220 shares of Geron...

      September 19 2024
      Business Wire

      Form 3 - Initial statement of beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer

      Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, announced the appointment of Jim Ziegler as Executive...

      September 09 2024
      Business Wire

      Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 261,000 shares of Geron...

      August 22 2024
      Business Wire

      Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights

      U.S. commercial launch of RYTELO™ (imetelstat) began in June 2024 for patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia who are relapsed/refractory to...

      August 08 2024
      Business Wire

      Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS

      RYTELO, for both RS+ and RS- patients, has a Category 1 recommendation for second-line treatment and a Category 2A recommendation for first-line treatment of patients who are ESA ineligible...

      July 26 2024
      Business Wire

      Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024

      Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice...

      July 23 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0250.5630630630634.444.8254.2301123504174.58672343CS
      4-0.075-1.651982378854.544.8254.2188163884.50269538CS
      120.1252.88018433184.345.064.1591528984.57232748CS
      261.16535.3030303033.35.343.05105433384.25793162CS
      522.325108.6448598132.145.341.6493704163.37420879CS
      1563.015207.9310344831.455.340.989960177562.91088431CS
      2603.035212.2377622381.435.340.7548891742.58419289CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 8.7001
      (107.15%)
      		49.1M
      MSSMaison Solutions Inc
      $ 1.37
      (91.61%)
      		77.74M
      SEELSeelos Therapeutics Inc
      $ 0.3419
      (79.95%)
      		297.35M
      XHGXChange TED Inc
      $ 0.9514
      (53.58%)
      		21.54M
      WVEWave Life Sciences Ltd
      $ 8.08
      (51.31%)
      		10M
      BIVIBioVie Inc
      $ 1.235
      (-55.89%)
      		1.84M
      GHSIGuardion Health Sciences Inc
      $ 6.63
      (-36.98%)
      		284.83k
      XPONExpion360 Inc
      $ 0.08885
      (-24.06%)
      		33.14M
      RSLSReShape Lifesciences Inc
      $ 6.1401
      (-23.15%)
      		594.63k
      LASELaser Photonics Corporation
      $ 14.8001
      (-21.28%)
      		2.8M
      SEELSeelos Therapeutics Inc
      $ 0.3429
      (80.47%)
      		297.35M
      NVDANVIDIA Corporation
      $ 120.895
      (3.99%)
      		191.05M
      SQQQProShares UltraPro Short QQQ
      $ 7.62
      (-1.93%)
      		90.46M
      MLGOMicroAlgo Inc
      $ 0.2217
      (11.74%)
      		81.38M
      MSSMaison Solutions Inc
      $ 1.369
      (91.47%)
      		77.74M

      GERN Discussion

      View Posts
      Stumblebum Stumblebum 15 hours ago
      He probably works at a market maker and gets paid to bash the stock cause his employer is shorting the shares…..that’s his job
      👍️ 2
      luckygm luckygm 21 hours ago
      Instead of complaining all the time, why don't you buy down here at sell when it goes up 10%. You could have made a fortune doing that over the past 6 months.
      👍️0
      Spike5 Spike5 21 hours ago
      Wow 10 % loss is a disaster . Now you know why I have not one good thing to say about this company . Management is making a killing and killing longs in the process .
      👍️0
      Spike5 Spike5 1 day ago
      This very well may be the dam breaking today … the shorts are going to keep driving this down to nothing . It’s a shame because this could have been a good thing but it is so poorly run and they have no news on anything coming out anytime soon . This amazes me that it cannot even get above five and now it’s going under 4 . Maybe even today
      👍️0
      Stumblebum Stumblebum 4 days ago
      These new hires are probably salespeople to push the imetelstat drug
      👍️0
      Stumblebum Stumblebum 4 days ago
      IMO a BO will occur next spring or summer once there is a definitive record of sales and forecast profitability…..$10 a share would be nice at the minimum
      👍️0
      attilathehunt attilathehunt 5 days ago
      Those new stock options announced after the close for newly hired 'ee's are an incentive to stay on in the very likely event of a BO...

      They will need them to stay on to ensure an orderly transition.

      BO before end of year is my prediction.
      👍️ 2
      big bambino big bambino 5 days ago
      closer & closer
      👍️0
      big bambino big bambino 5 days ago
      getting closer 7 closer to that sub $4 mark
      👍️0
      Stumblebum Stumblebum 7 days ago
      Ya they’re a bunch of bashing wussies
      👍️0
      learningcurve2020 learningcurve2020 1 week ago
      These weepers are so lazy they don't even post the news.

      >>We are thrilled to welcome Jim at this critical time when RYTELO is commercially available in the U.S. and we are seeing encouraging uptake since its launch at the end of June 2024,” said John A. Scarlett, M.D., Chairman and Chief Executive Officer
      👍️0
      big bambino big bambino 2 weeks ago
      This is why I pay no attention to these weeping little girls on this board. One day movement down and "the sky is falling, cash out before it goes below $4". From June price of approx $3,40 (per-approval) to today's price of $4.60, is what about 30% increase. So with no news it fluctuates from $4.70 - $4.20 (with no manipulation at all, ha). I don't need to post daily fluctuations because I'm not looking to influence anyone. I've been here long enough to wait a few more months to see direction. The one thing I do know is, this drug is a one of a king, with phenomenal results and in due time will produce results. If your a day trader, go for it. So much quieter with my ignore button 🤣
      👍️0
      Spike5 Spike5 2 weeks ago
      Gee what a surprise it’s giving yesterday back . What a terrible company !
      👍️0
      Spike5 Spike5 3 weeks ago
      Oh wow . This is done . A 14% loss at least in less than I week of trading on a $4.75 cent stock is a total disaster and goes to show that there is no foundation for this company . You better hope that their sales are off the charts . Unfortunately shorts are going to eventually win this one they are the only ones doing anything with this stock . No one is buying .
      👍️0
      Spike5 Spike5 3 weeks ago
      I wish you luck . However unfortunately it is being manipulated and the shorts are never going to let go of this until it is down to nothing .
      👍️0
      learningcurve2020 learningcurve2020 3 weeks ago
      Well, it is Geron after all. Fifteen years is a long time. We'll need to wait and see if revenues start rolling in or not. We should know soon.
      👍️0
      Spike5 Spike5 3 weeks ago
      No I do not think I will . I’m going to keep telling the truth about this company . I know democrats like you don’t like the truth
      👍️0
      Stumblebum Stumblebum 3 weeks ago
      Then leave
      👍️0
      Spike5 Spike5 3 weeks ago
      But you have to see some logic in the fact that this has been going on with this company for a long time and when it gets approval after many years it’s discouraging what has happened since . I’m sorry I don’t want to be like this because I do hope their drips helps people but I’m jaded with this company and cannot find anything good to say about it .
      👍️0
      learningcurve2020 learningcurve2020 3 weeks ago
      $2B l+ market isn't terrible until they can prove market penetration. A few things can happen now while we wait:

      1. Some unexpected new indication for the drug gets fast tracked.

      2. Some nasty side effect where the FDA puts a temporary hold on the drug.

      3. Buyout.

      👍️0
      Spike5 Spike5 3 weeks ago
      Absolutely nothing to drive this company . FDA approval was bullshit they have nothing left and it went nowhere . They should be in at least the twenties not trying to stay in the 4’s. It’s really sad how bad this company is being managed .
      👍️0
      seward seward 3 weeks ago
      added tiny order to flip
      👍️0
      Spike5 Spike5 3 weeks ago
      Oh wow ! Nothing else to say is over once it gets below 4 .
      👍️0
      Monksdream Monksdream 3 weeks ago
      GERN under $5
      👍️0
      Spike5 Spike5 4 weeks ago
      I just watch what it is doing do not follow it closely anymore . What is happening on Tuesday ?
      👍️0
      attilathehunt attilathehunt 4 weeks ago
      Let's see what Tuesday brings!
      👍️0
      Spike5 Spike5 4 weeks ago
      The geron giveback … three certainties death taxes and geron giveback
      👍️0
      Spike5 Spike5 1 month ago
      Where is that bigmouth big bambino . He has been awfully quiet . Probably because like I said you have fda approval and it cannot get above 5 dollars . Once again I am not shorting this stock I have not and never will short any stock but also once again I will not say a good word about how terrible this company is being ran . And also because I already lost a lot of money on this stock .
      👍️0
      Spike5 Spike5 1 month ago
      If this gets under 4 it’s over .
      👍️0
      Spike5 Spike5 1 month ago
      Wow …. This will be down to nothing soon … this company will never be worth shit because the people running it do not want it to be . I lost money back when this company did what it is doing now . No im not shorting this stock but I’m also not going to say anything good about this company . But you have delusional idiots on this board who think this is going up to a hundred . I don’t want to see what happened to me happen to others . I’m tired of management being the only ones making money
      👍️0
      Spike5 Spike5 1 month ago
      Total garbage
      👍️0
      Spike5 Spike5 2 months ago
      Ok that’s funny I’ll stop my nonsense .they are going to get a buy out for billions with sales that are not even one million. The truth hurts !
      👍️0
      learningcurve2020 learningcurve2020 2 months ago
      Stop your nonsense. They finally have revenues! Now it's only about growing pains, hopefully.

      >>08:59 AM EDT, 08/08/2024 (MT Newswires) -- Geron (GERN) reported a Q2 net loss Thursday of $0.10 per diluted share, widening from a loss of $0.09 a year earlier.

      Analysts polled by Capital IQ expected a per-share loss of $0.10.

      Revenue for the quarter ended June 30 was $882,000, up fro $29,000 a year earlier.

      Analysts surveyed by Capital IQ expected $290,000.

      As of June 30, the company said it had $430.4 million in cash, cash equivalents and marketable securities, which, together with projected revenue from US sales of Rytelo, will be enough to fund its expected operating requirements into Q2 of 2026.
      👍️0
      Spike5 Spike5 2 months ago
      Well sorry to people who thought this was going somewhere… unfortunately the shorts are going to win this one .
      👍️0
      attilathehunt attilathehunt 2 months ago
      Someone placed 19k on this weeks' 5 call options....They expect at least 5.10 in two days.
      👍️0
      Spike5 Spike5 2 months ago
      I have never seen a stock that cannot hold gains … it’s sad
      👍️0
      attilathehunt attilathehunt 2 months ago
      Lots of call options trading today!

      Someone truly likes the Jan 7 options!!
      👍️0
      Spike5 Spike5 2 months ago
      Oh boy this is going to get smashed today
      👍️0
      learningcurve2020 learningcurve2020 2 months ago
      "Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS"
      👍️0
      seward seward 2 months ago
      I wish I had bought every dip this year. But I loaded up on CDs instead.

      Still holding 3 positions.
      👍️0
      learningcurve2020 learningcurve2020 2 months ago
      LOL...A guy? You mean the Chief of Commercialization. Of course that's why it's down.

      >>This collaspe is not because of a guy leaving the company
      👍️0
      Spike5 Spike5 2 months ago
      This collaspe is not because of a guy leaving the company it’s because they have nothing new to offer and fda approval was an abject failure.and investors are scared
      👍️0
      learningcurve2020 learningcurve2020 2 months ago
      You just told people here he holds his shares when there's a Form 4 showing he sold and still holds some shares. I suspect you simply don't know how to read filings.
      👍️0
      big bambino big bambino 2 months ago
      Curve, I'm not giving out bad information. No one knows how many shares are still held by individuals. I'm also not disputing the sales of executives. That being said, no one knows why people sell shares. No one is expected to hold on forever, that is why we invest.
      👍️0
      learningcurve2020 learningcurve2020 2 months ago
      BigBambino giving out bad information. In fairness a number of execs sold around the same time on FDA approval. What's he have left about 170k shares?
      👍️0
      big bambino big bambino 2 months ago
      All I'm saying is, when I pull out of stock (whether with a loss or gain) I move on to my other or future holdings. To hang around a board and post regularly for years only to post negative views is basically concerning. To sell shares at a loss, deserves a negative response. But to hang around for years, with no skin in the game tends to send up red flags as to why. I myself being a long, will only view further post and restrain from engaging any further. Best of luck to all longs, which I believe will be rewarded. Seeing as we've already regained 5% back from loss's, let's wait and see 😀
      👍️ 1
      learningcurve2020 learningcurve2020 2 months ago
      That's what I suggested earlier. Almost seems too obvious so I'm skeptical...But hopeful.
      👍️0
      Stumblebum Stumblebum 2 months ago
      On June 10 of this year kapur sold 421,875 shares @$4.64…. Go to geron insider trading all activity is posted there ….not a good sign imo
      👍️0
      big bambino big bambino 2 months ago
      Maybe this was a decision with a possible takeover. Go and look for an alternate position somewhere else, since they wouldn't need 2 in that position. I think how the stocks end's up after Friday, may tell us a little more.
      👍️0
      learningcurve2020 learningcurve2020 2 months ago
      Not me. Geron has way too loooong a history of torturing shareholders. Waiting to see some actual market penetration.
      👍️0

      Your Recent History

      NASDAQ
      GERN
      Geron
      Delayed Upgrade Clock